首页> 外国专利> A solid pharmaceutical composition comprising at thiazolyl acid methyl ester 5S- (5R *, 8R, 10R *, 11R *) - 10-hydroxy-2-methyl-5- (1-methylethyl) -1- 2- (1-methylethyl) -4-thiazolyl -3,6-dioxo-8,11-bis (phenylmethyl) -2,4,7,12-tetraazatridecan-13-oic acid and a process for preparing

A solid pharmaceutical composition comprising at thiazolyl acid methyl ester 5S- (5R *, 8R, 10R *, 11R *) - 10-hydroxy-2-methyl-5- (1-methylethyl) -1- 2- (1-methylethyl) -4-thiazolyl -3,6-dioxo-8,11-bis (phenylmethyl) -2,4,7,12-tetraazatridecan-13-oic acid and a process for preparing

机译:一种固体药物组合物,其包含噻唑基甲酸甲酯[5S-(5R *,8R,10R *,11R *)]-10-羟基-2-甲基-5-(1-甲基乙基)-1- [2-(1 -(甲基乙基)-4-噻唑基] -3,6-二氧杂8,11-双(苯甲基)-2,4,7,12-四氮杂can十三-十三酸及其制备方法

摘要

A solid pharmaceutical composition comprising at thiazolyl acid methyl ester [5S- (5R *, 8R *, 10R *, 11R *)] - 10- hydroxy-2-methyl-5- (l-methylethyl) -1- [2 - (l-methylethyl) -4-thiazolyl] -3,6-dioxo-8,11-bis (phenylmethyl) -2,4,7,12-tetraazatridecan-13-oic acid and a compound which allows the penetration of gastrointestinal fluid said composition, which is selected from the group comprising lossilicatos and silica oxide, and a process for the preparation of this composition, comprising a kneading step inthe which the rate and time of addition of solvent is strictly controlled.
机译:一种固体药物组合物,其包含噻唑基甲酸甲酯[5S-(5R *,8R *,10R *,11R *)]-10-羟基-2-甲基-5-(1-甲基乙基)-1- [2--( [1-甲基乙基)-4-噻唑基] -3,6-二氧杂-8,11-双(苯基甲基)-2,4,7,12-四氮杂癸烷-13-油酸和允许胃肠液渗透的化合物组合物和制备该组合物的方法,该组合物选自包括损失的硅酮和氧化硅的组,所述捏合步骤严格控制溶剂的添加速度和时间。

著录项

相似文献

  • 专利
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号